Specifically, high MMP1 levels in BC have been shown to reduce the sensitivity of tumor cells to chemotherapeutic agents, whereas MMP1 inhibition significantly restores drug responsiveness in resistant cancer cells (52). Here, MMP1 is linked to breast cancer.